Rapid Relapse After Stopping Antipsychotics: Withdrawal or Relapse?
A 2026 analysis of paliperidone trials asks whether relapse after stopping is unusually rapid. A psychiatrist explains the findings, limits and what they mean.
Slow Taper Is Not Enough: Why Stopping an Antidepressant Should Come With Psychotherapy
A 2026 review found slow antidepressant tapering worked best for relapse prevention when paired with psychological support. Here’s what the evidence shows—and what it cannot tell us.
AI-Induced Mania: Is Your Chatbot Making You Mentally Unwell?
AI chatbots can't detect mania — and they may actively make it worse. A psychiatrist breaks down what the 2025 evidence shows, who is most vulnerable, and what clinical signs to watch for.
Can PCOS Affect Mental Health? What the Evidence Actually Shows
Women with PCOS are nearly four times more likely to have depression than women without it. A psychiatrist explains why the connection is neurobiological — not just emotional — and what it means for treatment.
PCOS Has a New Name. Here Is What PMOS Means for You.
PCOS has been officially renamed PMOS — polyendocrine metabolic ovarian syndrome. The change is not cosmetic. It reflects a fundamental shift in how medicine understands this condition, and it has real consequences for how women are diagnosed and treated.
Serotonergic Psychedelics as Antidepressants: What the Evidence Actually Shows
Psilocybin has re-entered psychiatric research with serious RCT data behind it. A psychiatrist reviews what the evidence actually shows — the neurobiology, the clinical trials, why some effect sizes are inflated, and why this is neither a miracle treatment nor a fringe idea.
AI Chatbots Are Not Safe for Psychosis or Mania: What the Research Now Shows
A review of reported psychiatric risks from AI chatbot use, including the limits of current evidence and when to seek professional help.
Psychedelics vs. Antidepressants: What the 2026 JAMA Psychiatry Data Actually Shows
A March 2026 JAMA Psychiatry meta-analysis found psychedelic-assisted therapy and open-label antidepressants produced equivalent outcomes. Before accepting that headline, it's worth understanding what the study actually measured — and why expectancy effects are the real story.
Is Social Media Making Your Child Less Intelligent? What the 2025–2026 Research Actually Shows
New research from JAMA and Karolinska links social media use in children aged 9–14 to lower reading, memory, and attention scores. A psychiatrist breaks down what the 2025–2026 data actually means — and what Indian parents can do about it.

